Jolkinolide A Inhibitor

Name: Jolkinolide A Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5762630
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5762630

Jolkinolide A has anti-tumor activity. It inhibited VEGF expression in A549 cells through the inhibition of the Akt-STAT3-mTOR signaling pathway, and directly inhibited the proliferation and migration of HUVECs. More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Jolkinolide A, Inhibitor

Full Product Name

Jolkinolide A

Form/Format

Solid. Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

314.4

Solubility

<1mg/ml refers to the product slightly soluble or insoluble

Formula

C20H26O3

CAS Number

37905-07-0

Target & IC50

Akt
mTOR
STAT
VEGF

Product Categories/Family for Jolkinolide A, inhibitor

Cytoskeletal Signaling; Akt; JAK/STAT signaling; Stem Cells; PI3K/Akt/mTOR signaling

Product References and Citations for Jolkinolide A, inhibitor

Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells. Medical Science Monitor, 2017, 23:223-237.
Cytotoxic diterpenoids from the roots of Euphorbia ebracteolata. Planta Medica, 2005, 71(4):349-354.

Other Notes

Small volumes of Jolkinolide A, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Jolkinolide A purchase

MBS5762630 is an inhibitor targeting Jolkinolide A.